Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
AIP1: a new player in TNF signaling
M. Eugenia Guicciardi, Gregory J. Gores
M. Eugenia Guicciardi, Gregory J. Gores
Published June 15, 2003
Citation Information: J Clin Invest. 2003;111(12):1813-1815. https://doi.org/10.1172/JCI18911.
View: Text | PDF
Commentary

AIP1: a new player in TNF signaling

  • Text
  • PDF
Abstract

Apoptosis signal–regulating kinase 1 (ASK1) is an upstream activator of JNK and p38 MAPK signaling cascades. Evidence now shows that the ASK1-interacting protein, AIP1, plays an important role in TNF-α–induced ASK1 activation by facilitating dissociation from its inhibitor.

Authors

M. Eugenia Guicciardi, Gregory J. Gores

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
(a) Generic schema for the cytokine/adaptor/MAPK signaling paradigm. Cyt...
(a) Generic schema for the cytokine/adaptor/MAPK signaling paradigm. Cytokines, such as TNF-α, trigger oligomerization of their enzymatically inactive cognate receptors. The conformational change in the receptor complex following ligand binding facilitates recruitment of adaptor proteins. These adaptor proteins within the receptor complex interact directly or indirectly with upstream kinases (MAPKKK) permitting their activation with subsequent phosphorylation and activation of downstream kinases (MAPKK/MAPK). (b) Model of TNF-α signaling pathway through TRAF2/ASK1 employing the cytokine/adaptor/MAPK paradigm. Triggering of TNF-R1 leads to recruitment of the adaptor TRAF2, and concomitant activation of an unknown phosphatase via a mechanism yet to be identified. TRAF2 mediates the association of ASK1 with the newly identified Ras-GAP AIP1, which facilitates the release of ASK1 from its endogenous inhibitor 14-3-3. Disruption of the ASK1/14-3-3 complex and de-phosphorylation of ASK1 by the unknown phosphatase result in the activation of ASK1. ASK1, in turn, activates JNK via an MKK4- or MKK6-dependent pathway. Activation of JNK positively regulates the apoptotic machinery by transcription-dependent (i.e., activation of the transcription factor AP-1) and transcription-independent (i.e., phosphorylation and activation of proapototic Bcl-2 proteins Bim and Bmf) mechanisms. P, phosphate.

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts